-
1
-
-
79955629384
-
Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines
-
Stenzl A., Cowan N.C., De Santis M., et al. Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines. Eur Urol 2011, 59:1009-1018.
-
(2011)
Eur Urol
, vol.59
, pp. 1009-1018
-
-
Stenzl, A.1
Cowan, N.C.2
De Santis, M.3
-
2
-
-
0017714612
-
Survival following transurethral resection of bladder carcinoma
-
Barnee R.W., Dick A.L., Hadley H.L., et al. Survival following transurethral resection of bladder carcinoma. Cancer Res 1997, 37:2895-2897.
-
(1997)
Cancer Res
, vol.37
, pp. 2895-2897
-
-
Barnee, R.W.1
Dick, A.L.2
Hadley, H.L.3
-
3
-
-
0023733498
-
Comparison of transurethral resection to radical therapies for stage B bladder tumors
-
Henry K., Miller J., Mori M., et al. Comparison of transurethral resection to radical therapies for stage B bladder tumors. J Urol 1988, 140:964-967.
-
(1988)
J Urol
, vol.140
, pp. 964-967
-
-
Henry, K.1
Miller, J.2
Mori, M.3
-
4
-
-
0016751395
-
Transurethral resection for the assessment and treatment of vesical neoplasms: a review of 840 consecutive cases
-
O'Flynn J.D., Smith J.D., Hanson J.S., et al. Transurethral resection for the assessment and treatment of vesical neoplasms: a review of 840 consecutive cases. Eur Urol 1975, 1:38-40.
-
(1975)
Eur Urol
, vol.1
, pp. 38-40
-
-
O'Flynn, J.D.1
Smith, J.D.2
Hanson, J.S.3
-
5
-
-
0023205227
-
Conservative management of muscle-infiltrating bladder cancer: prospective experience
-
Herr H.W. Conservative management of muscle-infiltrating bladder cancer: prospective experience. J Urol 1987, 138:1162-1163.
-
(1987)
J Urol
, vol.138
, pp. 1162-1163
-
-
Herr, H.W.1
-
6
-
-
77955472338
-
Feasibility of radical transurethral resection as monotherapy for selected patients with muscle invasive bladder cancer
-
Solsona E., Iborra I., Collado A., et al. Feasibility of radical transurethral resection as monotherapy for selected patients with muscle invasive bladder cancer. J Urol 2010, 184:475-481.
-
(2010)
J Urol
, vol.184
, pp. 475-481
-
-
Solsona, E.1
Iborra, I.2
Collado, A.3
-
7
-
-
0035154545
-
Transurethral resection of muscle-invasive bladder cancer: 10-year outcome
-
Herr H.W. Transurethral resection of muscle-invasive bladder cancer: 10-year outcome. J Clin Oncol 2001, 19:89-93.
-
(2001)
J Clin Oncol
, vol.19
, pp. 89-93
-
-
Herr, H.W.1
-
8
-
-
0030453355
-
VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development
-
Kukk E., Lymboussaki A., Taira S., et al. VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development. Development 1996, 122:3829-3837.
-
(1996)
Development
, vol.122
, pp. 3829-3837
-
-
Kukk, E.1
Lymboussaki, A.2
Taira, S.3
-
9
-
-
0037139421
-
Correlation between vascular endothelial growth factor-C expression and invasion phenotype in cervical carcinomas
-
Ueda M., Terai Y., Yamashita Y., et al. Correlation between vascular endothelial growth factor-C expression and invasion phenotype in cervical carcinomas. Int J Cancer 2002, 98:335-343.
-
(2002)
Int J Cancer
, vol.98
, pp. 335-343
-
-
Ueda, M.1
Terai, Y.2
Yamashita, Y.3
-
10
-
-
33749578614
-
Vascular endothelial growth factor-C (VEGF-C) expression in bladder transitional cell cancer and its relationship to lymph node metastasis
-
Zu X.B., Tang Z.Y., Li Y., et al. Vascular endothelial growth factor-C (VEGF-C) expression in bladder transitional cell cancer and its relationship to lymph node metastasis. BJU Int 2006, 98:1090-1093.
-
(2006)
BJU Int
, vol.98
, pp. 1090-1093
-
-
Zu, X.B.1
Tang, Z.Y.2
Li, Y.3
-
11
-
-
0037099683
-
Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results
-
Rodel C., Grabenbauer G.G., Kuhn R., et al. Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results. J Clin Oncol 2002, 20:3061-3071.
-
(2002)
J Clin Oncol
, vol.20
, pp. 3061-3071
-
-
Rodel, C.1
Grabenbauer, G.G.2
Kuhn, R.3
-
12
-
-
0031985484
-
Efficacy of radio-chemotherapy with platin derivatives compared to radiotherapy alone in organ-sparing treatment of bladder cancer
-
Sauer R., Birkenhake S., Kuhn R., et al. Efficacy of radio-chemotherapy with platin derivatives compared to radiotherapy alone in organ-sparing treatment of bladder cancer. Int J Radiat Oncol Biol Phys 1998, 40:121-127.
-
(1998)
Int J Radiat Oncol Biol Phys
, vol.40
, pp. 121-127
-
-
Sauer, R.1
Birkenhake, S.2
Kuhn, R.3
-
13
-
-
0031986427
-
Feasibility of transurethral resection for muscle-infiltrating carcinoma of the bladder: long-term follow-up of a prospective study
-
Solsona E., Iborra I., Ricos J.V., et al. Feasibility of transurethral resection for muscle-infiltrating carcinoma of the bladder: long-term follow-up of a prospective study. J Urol 1998, 159:95-99.
-
(1998)
J Urol
, vol.159
, pp. 95-99
-
-
Solsona, E.1
Iborra, I.2
Ricos, J.V.3
-
14
-
-
0030030350
-
Neoadjuvant combined modality therapy with possible organ preservation for invasive bladder cancer
-
Tester W., Porter A., Heaney J., et al. Neoadjuvant combined modality therapy with possible organ preservation for invasive bladder cancer. J Clin Oncol 1996, 14:119-126.
-
(1996)
J Clin Oncol
, vol.14
, pp. 119-126
-
-
Tester, W.1
Porter, A.2
Heaney, J.3
-
15
-
-
0027452436
-
Combined radiation and chemotherapy for invasive transitional cell carcinoma of the bladder: a prospective study
-
Housset M., Maulard C., Chretien Y.C., et al. Combined radiation and chemotherapy for invasive transitional cell carcinoma of the bladder: a prospective study. J Clin Oncol 1993, 11:2150-2157.
-
(1993)
J Clin Oncol
, vol.11
, pp. 2150-2157
-
-
Housset, M.1
Maulard, C.2
Chretien, Y.C.3
-
16
-
-
0035254218
-
Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients
-
Stein J.P., Lieskovsky G., Cote R., et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 2001, 19:666-675.
-
(2001)
J Clin Oncol
, vol.19
, pp. 666-675
-
-
Stein, J.P.1
Lieskovsky, G.2
Cote, R.3
-
17
-
-
0037446128
-
Overview of bladder cancer trials in the Radiation Therapy Oncology Group
-
Shipley W.U., Kaufman D.S., Tester W.J., et al. Overview of bladder cancer trials in the Radiation Therapy Oncology Group. Cancer 2003, 97:2115-2119.
-
(2003)
Cancer
, vol.97
, pp. 2115-2119
-
-
Shipley, W.U.1
Kaufman, D.S.2
Tester, W.J.3
-
18
-
-
0031763392
-
Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy: initial results of Radiation Therapy Oncology Group 89-03
-
Shipley W.U., Winter K.A., Kaufman D.S., et al. Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy: initial results of Radiation Therapy Oncology Group 89-03. J Clin Oncol 1998, 16:3576-3583.
-
(1998)
J Clin Oncol
, vol.16
, pp. 3576-3583
-
-
Shipley, W.U.1
Winter, K.A.2
Kaufman, D.S.3
-
19
-
-
26444442355
-
Organ-sparing treatment in muscle-invasive bladder cancer
-
Dunst J., Diestelhomt A., Kohn R., et al. Organ-sparing treatment in muscle-invasive bladder cancer. Strahlenther Onkol 2005, 181:632-637.
-
(2005)
Strahlenther Onkol
, vol.181
, pp. 632-637
-
-
Dunst, J.1
Diestelhomt, A.2
Kohn, R.3
-
20
-
-
0036290017
-
Selective bladder preservation by combined modal protocol treatment: long-term outcomes of 190 patients with invasive bladder cancer
-
Shipley W.U., Kaufman D.S., Zehr E., et al. Selective bladder preservation by combined modal protocol treatment: long-term outcomes of 190 patients with invasive bladder cancer. Urology 2002, 60:62-67.
-
(2002)
Urology
, vol.60
, pp. 62-67
-
-
Shipley, W.U.1
Kaufman, D.S.2
Zehr, E.3
-
21
-
-
0025971521
-
Carcinoma in situ associated with superficial bladder tumor
-
Solsona E., Iborra I., Rids J.V., et al. Carcinoma in situ associated with superficial bladder tumor. Eur Urol 1991, 19:93-96.
-
(1991)
Eur Urol
, vol.19
, pp. 93-96
-
-
Solsona, E.1
Iborra, I.2
Rids, J.V.3
-
22
-
-
0032847686
-
The impact of pelvic lymphadenectomy and radical cystectomy on outcome in lymph node positive bladder cancer
-
Vieweg J., Gschwend J., Herr H.W., et al. The impact of pelvic lymphadenectomy and radical cystectomy on outcome in lymph node positive bladder cancer. J Urol 1999, 161:72-76.
-
(1999)
J Urol
, vol.161
, pp. 72-76
-
-
Vieweg, J.1
Gschwend, J.2
Herr, H.W.3
-
23
-
-
0035515609
-
Molecular markers for diagnosis, staging and prognosis of bladder cancer
-
Williams S.G., Buscarini M., Stein J.P., et al. Molecular markers for diagnosis, staging and prognosis of bladder cancer. Oncology 2001, 15:1461-1484.
-
(2001)
Oncology
, vol.15
, pp. 1461-1484
-
-
Williams, S.G.1
Buscarini, M.2
Stein, J.P.3
-
24
-
-
0942298834
-
Vascular endothelial growth factor-C and vascular endothelial growth factor-d messenger RNA expression in breast cancer: association with lymph node metastasis
-
Koyama Y., Kaneko K., Akazawa K., et al. Vascular endothelial growth factor-C and vascular endothelial growth factor-d messenger RNA expression in breast cancer: association with lymph node metastasis. Clin Breast Cancer 2003, 4:354-360.
-
(2003)
Clin Breast Cancer
, vol.4
, pp. 354-360
-
-
Koyama, Y.1
Kaneko, K.2
Akazawa, K.3
-
25
-
-
1142275254
-
Expression of VEGF-C and VEGF-D at the invasive edge correlates with lymph node metastasis and prognosis of patients with colorectal carcinoma
-
Onogawa S., Kitadai Y., Tanaka S., et al. Expression of VEGF-C and VEGF-D at the invasive edge correlates with lymph node metastasis and prognosis of patients with colorectal carcinoma. Cancer Sci 2004, 95:32-39.
-
(2004)
Cancer Sci
, vol.95
, pp. 32-39
-
-
Onogawa, S.1
Kitadai, Y.2
Tanaka, S.3
-
26
-
-
0037267293
-
Expression of vascular endothelial growth factor C and D (VEGF-C and -D) is an important risk factor for lymphatic metastasis in undifferentiated early gastric carcinoma
-
Ishikawa M., Kitayama J., Kazama S., et al. Expression of vascular endothelial growth factor C and D (VEGF-C and -D) is an important risk factor for lymphatic metastasis in undifferentiated early gastric carcinoma. Jpn J Clin Oncol 2003, 33:21-27.
-
(2003)
Jpn J Clin Oncol
, vol.33
, pp. 21-27
-
-
Ishikawa, M.1
Kitayama, J.2
Kazama, S.3
-
27
-
-
4143145525
-
Clinical implication of expression of vascular endothelial growth factor-C in metastatic lymph nodes of uterine cervical cancers
-
Fujimoto J., Toyoki H., Sato E., et al. Clinical implication of expression of vascular endothelial growth factor-C in metastatic lymph nodes of uterine cervical cancers. Br J Cancer 2004, 91:466-469.
-
(2004)
Br J Cancer
, vol.91
, pp. 466-469
-
-
Fujimoto, J.1
Toyoki, H.2
Sato, E.3
-
28
-
-
0042384574
-
Expression of vascular endothelial growth factor-C in benign and malignant thyroid tumors
-
Hung C.J., Ginzinger D.G., Zarnegar R., et al. Expression of vascular endothelial growth factor-C in benign and malignant thyroid tumors. J Clin Endocrinol Metab 2003, 88:3694-3699.
-
(2003)
J Clin Endocrinol Metab
, vol.88
, pp. 3694-3699
-
-
Hung, C.J.1
Ginzinger, D.G.2
Zarnegar, R.3
-
29
-
-
0037439321
-
Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma
-
Arinaga M., Noguchi T., Takeno S., et al. Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma. Cancer 2003, 97:457-464.
-
(2003)
Cancer
, vol.97
, pp. 457-464
-
-
Arinaga, M.1
Noguchi, T.2
Takeno, S.3
|